Labo Euromedis (XPAR:ALEMG) EV-to-EBIT : 0.17 (As of Jun. 12, 2024)

Labo Euromedis EV-to-EBIT Chart

Labo Euromedis Annual Data
	Trend	Jul13	Jul14	Jul15	Jul16	Jul17	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-EBIT		Get a 7-Day Free Trial					-9.37	1.49	5.38	-0.05	0.29

Labo Euromedis Semi-Annual Data
	Jul13	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															5.38	-	-0.05	-	-

Competitive Comparison of Labo Euromedis's EV-to-EBIT

For the Medical Devices subindustry, Labo Euromedis's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Labo Euromedis's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Labo Euromedis's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Labo Euromedis's EV-to-EBIT falls into.

Labo Euromedis EV-to-EBIT Calculation

Labo Euromedis's EV-to-EBIT for today is calculated as:

Labo Euromedis's current Enterprise Value is €3.65 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Labo Euromedis's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €22.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labo Euromedis  (XPAR:ALEMG) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Labo Euromedis's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

Labo Euromedis's Enterprise Value for the quarter that ended in Jun. 2023 was €2.54 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Labo Euromedis's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €22.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labo Euromedis EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Labo Euromedis's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Labo Euromedis (XPAR:ALEMG) Business Description